The company said that all 10 patients reached the secondary endpoint for measurement of tumor response to its alpha-radiation cancer therapy.
Read more here.
![[Peak in Tech Crunch] Peak AI nabs $21M for a platform to help non-tech companies make AI-based decisions](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[Peak in Tech Crunch] Peak AI nabs $21M for a platform to help non-tech companies make AI-based decisions
February 17, 2021
[NanoLock in Smart Industry] Industrial cybersecurity: Be informed, be very, very informed
February 16, 2022
